Mortality Effect of ICD in Primary Prevention of Nonischemic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials

Faraz Khan Luni, Hemindermeet Singh, Abdur R. Khan, Sonia A. Malik, Owais Khawaja, Haris Riaz, Wade Lee, Ameer Kabour, Mark Richards, Johan Aasbo

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Introduction: Implantation of an implantable cardioverter defibrillator (ICD) for primary prevention of sudden cardiac death (SCD) is controversial in view of the recent DANISH trial which suggested no benefit with ICD for primary prevention in patients with non-ischemic cardiomyopathy (NICMP). Methods: We conducted a meta-analysis of randomized control trials studying the role of ICD in primary prevention of SCD in patients with NICMP. Only six studies were identified after the application of inclusion/exclusion criteria. Results: Pooling of these randomized trials showed a statistically significant benefit of using ICDs in patients with NICMP [OR 0.76 (0.64 – 0.91), I2 = 0%]. Sensitivity analysis did not show a statistically significant mortality benefit of ICD in NICMP in trials which had adequate beta blocker, ACE/ARB and aldosterone receptor blocker (ALD-RB) use [OR 0.70 (0.41, 1.19), I2 = 70%]. Conclusion: The DANISH trial's failure to show mortality benefit may be due to the significant number of patients who had CRT. Our meta-analysis studied the independent effect of ICDs and showed them to be associated with net mortality benefits in patients who are not on optimal guideline directed medical therapy; especially the patients not on ALD-RB.

Original languageEnglish (US)
Pages (from-to)538-543
Number of pages6
JournalJournal of Cardiovascular Electrophysiology
Volume28
Issue number5
DOIs
StatePublished - May 2017
Externally publishedYes

Fingerprint

Implantable Defibrillators
Primary Prevention
Cardiomyopathies
Meta-Analysis
Randomized Controlled Trials
Mortality
Mineralocorticoid Receptors
Sudden Cardiac Death
Guidelines

Keywords

  • DANISH trial
  • implantable cardioverter defibrillator
  • meta-analysis
  • nonischemic cardiomyopathy
  • sudden cardiac death

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Mortality Effect of ICD in Primary Prevention of Nonischemic Cardiomyopathy : A Meta-Analysis of Randomized Controlled Trials. / Luni, Faraz Khan; Singh, Hemindermeet; Khan, Abdur R.; Malik, Sonia A.; Khawaja, Owais; Riaz, Haris; Lee, Wade; Kabour, Ameer; Richards, Mark; Aasbo, Johan.

In: Journal of Cardiovascular Electrophysiology, Vol. 28, No. 5, 05.2017, p. 538-543.

Research output: Contribution to journalArticle

Luni, Faraz Khan ; Singh, Hemindermeet ; Khan, Abdur R. ; Malik, Sonia A. ; Khawaja, Owais ; Riaz, Haris ; Lee, Wade ; Kabour, Ameer ; Richards, Mark ; Aasbo, Johan. / Mortality Effect of ICD in Primary Prevention of Nonischemic Cardiomyopathy : A Meta-Analysis of Randomized Controlled Trials. In: Journal of Cardiovascular Electrophysiology. 2017 ; Vol. 28, No. 5. pp. 538-543.
@article{dbddf759f3434a3fb8d558cdbfa9dc3c,
title = "Mortality Effect of ICD in Primary Prevention of Nonischemic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials",
abstract = "Introduction: Implantation of an implantable cardioverter defibrillator (ICD) for primary prevention of sudden cardiac death (SCD) is controversial in view of the recent DANISH trial which suggested no benefit with ICD for primary prevention in patients with non-ischemic cardiomyopathy (NICMP). Methods: We conducted a meta-analysis of randomized control trials studying the role of ICD in primary prevention of SCD in patients with NICMP. Only six studies were identified after the application of inclusion/exclusion criteria. Results: Pooling of these randomized trials showed a statistically significant benefit of using ICDs in patients with NICMP [OR 0.76 (0.64 – 0.91), I2 = 0{\%}]. Sensitivity analysis did not show a statistically significant mortality benefit of ICD in NICMP in trials which had adequate beta blocker, ACE/ARB and aldosterone receptor blocker (ALD-RB) use [OR 0.70 (0.41, 1.19), I2 = 70{\%}]. Conclusion: The DANISH trial's failure to show mortality benefit may be due to the significant number of patients who had CRT. Our meta-analysis studied the independent effect of ICDs and showed them to be associated with net mortality benefits in patients who are not on optimal guideline directed medical therapy; especially the patients not on ALD-RB.",
keywords = "DANISH trial, implantable cardioverter defibrillator, meta-analysis, nonischemic cardiomyopathy, sudden cardiac death",
author = "Luni, {Faraz Khan} and Hemindermeet Singh and Khan, {Abdur R.} and Malik, {Sonia A.} and Owais Khawaja and Haris Riaz and Wade Lee and Ameer Kabour and Mark Richards and Johan Aasbo",
year = "2017",
month = "5",
doi = "10.1111/jce.13192",
language = "English (US)",
volume = "28",
pages = "538--543",
journal = "Journal of Cardiovascular Electrophysiology",
issn = "1045-3873",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Mortality Effect of ICD in Primary Prevention of Nonischemic Cardiomyopathy

T2 - A Meta-Analysis of Randomized Controlled Trials

AU - Luni, Faraz Khan

AU - Singh, Hemindermeet

AU - Khan, Abdur R.

AU - Malik, Sonia A.

AU - Khawaja, Owais

AU - Riaz, Haris

AU - Lee, Wade

AU - Kabour, Ameer

AU - Richards, Mark

AU - Aasbo, Johan

PY - 2017/5

Y1 - 2017/5

N2 - Introduction: Implantation of an implantable cardioverter defibrillator (ICD) for primary prevention of sudden cardiac death (SCD) is controversial in view of the recent DANISH trial which suggested no benefit with ICD for primary prevention in patients with non-ischemic cardiomyopathy (NICMP). Methods: We conducted a meta-analysis of randomized control trials studying the role of ICD in primary prevention of SCD in patients with NICMP. Only six studies were identified after the application of inclusion/exclusion criteria. Results: Pooling of these randomized trials showed a statistically significant benefit of using ICDs in patients with NICMP [OR 0.76 (0.64 – 0.91), I2 = 0%]. Sensitivity analysis did not show a statistically significant mortality benefit of ICD in NICMP in trials which had adequate beta blocker, ACE/ARB and aldosterone receptor blocker (ALD-RB) use [OR 0.70 (0.41, 1.19), I2 = 70%]. Conclusion: The DANISH trial's failure to show mortality benefit may be due to the significant number of patients who had CRT. Our meta-analysis studied the independent effect of ICDs and showed them to be associated with net mortality benefits in patients who are not on optimal guideline directed medical therapy; especially the patients not on ALD-RB.

AB - Introduction: Implantation of an implantable cardioverter defibrillator (ICD) for primary prevention of sudden cardiac death (SCD) is controversial in view of the recent DANISH trial which suggested no benefit with ICD for primary prevention in patients with non-ischemic cardiomyopathy (NICMP). Methods: We conducted a meta-analysis of randomized control trials studying the role of ICD in primary prevention of SCD in patients with NICMP. Only six studies were identified after the application of inclusion/exclusion criteria. Results: Pooling of these randomized trials showed a statistically significant benefit of using ICDs in patients with NICMP [OR 0.76 (0.64 – 0.91), I2 = 0%]. Sensitivity analysis did not show a statistically significant mortality benefit of ICD in NICMP in trials which had adequate beta blocker, ACE/ARB and aldosterone receptor blocker (ALD-RB) use [OR 0.70 (0.41, 1.19), I2 = 70%]. Conclusion: The DANISH trial's failure to show mortality benefit may be due to the significant number of patients who had CRT. Our meta-analysis studied the independent effect of ICDs and showed them to be associated with net mortality benefits in patients who are not on optimal guideline directed medical therapy; especially the patients not on ALD-RB.

KW - DANISH trial

KW - implantable cardioverter defibrillator

KW - meta-analysis

KW - nonischemic cardiomyopathy

KW - sudden cardiac death

UR - http://www.scopus.com/inward/record.url?scp=85016987763&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85016987763&partnerID=8YFLogxK

U2 - 10.1111/jce.13192

DO - 10.1111/jce.13192

M3 - Article

C2 - 28370885

AN - SCOPUS:85016987763

VL - 28

SP - 538

EP - 543

JO - Journal of Cardiovascular Electrophysiology

JF - Journal of Cardiovascular Electrophysiology

SN - 1045-3873

IS - 5

ER -